Crestwood Advisors Group LLC Raises Holdings in Danaher Co. (NYSE:DHR)

Crestwood Advisors Group LLC increased its holdings in shares of Danaher Co. (NYSE:DHR) by 0.4% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 333,248 shares of the conglomerate’s stock after purchasing an additional 1,264 shares during the period. Danaher accounts for approximately 1.8% of Crestwood Advisors Group LLC’s holdings, making the stock its 10th largest position. Crestwood Advisors Group LLC’s holdings in Danaher were worth $92,649,000 at the end of the most recent quarter.

A number of other institutional investors have also recently bought and sold shares of DHR. Norden Group LLC acquired a new position in Danaher in the 1st quarter valued at about $276,000. Mutual Advisors LLC grew its holdings in Danaher by 0.8% in the 1st quarter. Mutual Advisors LLC now owns 6,170 shares of the conglomerate’s stock valued at $1,541,000 after buying an additional 47 shares in the last quarter. Callan Capital LLC bought a new position in Danaher during the 1st quarter worth $252,000. Avidian Wealth Solutions LLC lifted its holdings in shares of Danaher by 64.6% during the first quarter. Avidian Wealth Solutions LLC now owns 2,565 shares of the conglomerate’s stock worth $640,000 after buying an additional 1,007 shares in the last quarter. Finally, Catalina Capital Group LLC bought a new stake in shares of Danaher in the first quarter valued at about $642,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analyst Ratings Changes

Several brokerages have weighed in on DHR. KeyCorp lifted their price objective on shares of Danaher from $290.00 to $310.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 23rd. Evercore ISI boosted their price target on Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a research note on Tuesday, October 1st. Leerink Partners raised their price target on Danaher from $275.00 to $280.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 24th. Royal Bank of Canada lowered their price objective on shares of Danaher from $333.00 to $311.00 and set an “outperform” rating for the company in a research report on Wednesday, October 23rd. Finally, Stephens reissued an “overweight” rating and set a $315.00 price target on shares of Danaher in a report on Wednesday, October 23rd. Six equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and an average price target of $287.16.

Danaher Trading Down 0.1 %

NYSE:DHR traded down $0.29 on Tuesday, reaching $246.89. 76,156 shares of the stock traded hands, compared to its average volume of 2,735,731. The firm has a market capitalization of $178.32 billion, a price-to-earnings ratio of 47.17, a price-to-earnings-growth ratio of 4.55 and a beta of 0.85. Danaher Co. has a 1-year low of $192.35 and a 1-year high of $281.70. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32. The company’s 50 day moving average is $266.53 and its 200-day moving average is $260.74.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. The business had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. Danaher’s quarterly revenue was up 3.1% on a year-over-year basis. During the same quarter last year, the firm earned $2.02 earnings per share. Equities research analysts anticipate that Danaher Co. will post 7.51 EPS for the current fiscal year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were issued a $0.27 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 dividend on an annualized basis and a yield of 0.44%. Danaher’s payout ratio is currently 20.61%.

Insider Buying and Selling at Danaher

In other news, SVP Georgeann Couchara sold 952 shares of Danaher stock in a transaction on Monday, August 26th. The shares were sold at an average price of $268.37, for a total value of $255,488.24. Following the completion of the sale, the senior vice president now owns 4,212 shares in the company, valued at $1,130,374.44. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 10.90% of the company’s stock.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.